28292183|t|N-Docosahexaenoyl Dopamine, an Endocannabinoid-like Conjugate of Dopamine and the n-3 Fatty Acid Docosahexaenoic Acid, Attenuates Lipopolysaccharide-Induced Activation of Microglia and Macrophages via COX-2.
28292183|a|Several studies indicate that the n-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA) contributes to an attenuated inflammatory status in the development of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease. To explain these effects, different mechanisms are being proposed, including those involving endocannabinoids and related signaling molecules. Many of these compounds belong to the fatty acid amides, conjugates of fatty acids with biogenic amines. Conjugates of DHA with ethanolamine or serotonin have previously been shown to possess anti-inflammatory and potentially neuroprotective properties. Here, we synthesized another amine conjugate of DHA, N-docosahexaenoyl dopamine (DHDA), and tested its immune-modulatory properties in both RAW 264.7 macrophages and BV-2 microglial cells. N-Docosahexaenoyl dopamine significantly suppressed the production of nitric oxide (NO), the cytokine interleukin-6 (IL-6), and the chemokines macrophage-inflammatory protein-3alpha (CCL20) and monocyte chemoattractant protein-1 (MCP-1), whereas its parent compounds, dopamine and DHA, were ineffective. Further exploration of potential effects of DHDA on key inflammatory mediators revealed that cyclooxygenase-2 (COX-2) mRNA level and production of prostaglandin E2 (PGE2) were concentration-dependently inhibited in macrophages. In activated BV-2 cells, PGE2 production was also reduced, without changes in COX-2 mRNA levels. In addition, DHDA did not affect NF-kB activity in a reporter cell line. Finally, the immune-modulatory activities of DHDA were compared with those of N-arachidonoyl dopamine (NADA) and similar potencies were found in both cell types. Taken together, our data suggest that DHDA, a potentially endogenous endocannabinoid, may be an additional member of the group of immune-modulating n-3 fatty acid-derived lipid mediators.
28292183	0	26	N-Docosahexaenoyl Dopamine	Chemical	MESH:C520236
28292183	31	46	Endocannabinoid	Chemical	MESH:D063388
28292183	65	73	Dopamine	Chemical	MESH:D004298
28292183	82	117	n-3 Fatty Acid Docosahexaenoic Acid	Chemical	-
28292183	130	148	Lipopolysaccharide	Chemical	MESH:D008070
28292183	201	206	COX-2	Gene	19225
28292183	242	283	n-3 long-chain polyunsaturated fatty acid	Chemical	-
28292183	284	304	docosahexaenoic acid	Chemical	MESH:D004281
28292183	306	309	DHA	Chemical	MESH:D004281
28292183	340	352	inflammatory	Disease	MESH:D007249
28292183	382	409	neurodegenerative disorders	Disease	MESH:D019636
28292183	419	454	Alzheimer's and Parkinson's disease	Disease	MESH:D010300
28292183	549	565	endocannabinoids	Chemical	MESH:D063388
28292183	637	654	fatty acid amides	Chemical	-
28292183	670	681	fatty acids	Chemical	MESH:D005227
28292183	696	702	amines	Chemical	MESH:D000588
28292183	718	721	DHA	Chemical	MESH:D004281
28292183	727	739	ethanolamine	Chemical	MESH:D019856
28292183	743	752	serotonin	Chemical	MESH:D012701
28292183	796	808	inflammatory	Disease	MESH:D007249
28292183	882	887	amine	Chemical	MESH:D000588
28292183	901	904	DHA	Chemical	MESH:D004281
28292183	906	932	N-docosahexaenoyl dopamine	Chemical	MESH:C520236
28292183	934	938	DHDA	Chemical	MESH:C520236
28292183	993	1002	RAW 264.7	CellLine	CVCL:0493
28292183	1019	1023	BV-2	CellLine	CVCL:0182
28292183	1042	1068	N-Docosahexaenoyl dopamine	Chemical	MESH:C520236
28292183	1112	1124	nitric oxide	Chemical	MESH:D009569
28292183	1144	1157	interleukin-6	Gene	16193
28292183	1159	1163	IL-6	Gene	16193
28292183	1185	1223	macrophage-inflammatory protein-3alpha	Gene	20297
28292183	1225	1230	CCL20	Gene	20297
28292183	1236	1270	monocyte chemoattractant protein-1	Gene	20296
28292183	1272	1277	MCP-1	Gene	20296
28292183	1310	1318	dopamine	Chemical	MESH:D004298
28292183	1323	1326	DHA	Chemical	MESH:D004281
28292183	1390	1394	DHDA	Chemical	MESH:C520236
28292183	1402	1414	inflammatory	Disease	MESH:D007249
28292183	1439	1455	cyclooxygenase-2	Gene	19225
28292183	1457	1462	COX-2	Gene	19225
28292183	1587	1591	BV-2	CellLine	CVCL:0182
28292183	1652	1657	COX-2	Gene	19225
28292183	1684	1688	DHDA	Chemical	MESH:C520236
28292183	1789	1793	DHDA	Chemical	MESH:C520236
28292183	1822	1845	N-arachidonoyl dopamine	Chemical	MESH:C474941
28292183	1847	1851	NADA	Chemical	MESH:C474941
28292183	1944	1948	DHDA	Chemical	MESH:C520236
28292183	1975	1990	endocannabinoid	Chemical	MESH:D063388
28292183	2054	2068	n-3 fatty acid	Chemical	MESH:D015525
28292183	2077	2082	lipid	Chemical	MESH:D008055
28292183	Negative_Correlation	MESH:C520236	MESH:D009569
28292183	Negative_Correlation	MESH:C520236	MESH:D008070
28292183	Association	MESH:D004281	MESH:D012701
28292183	Negative_Correlation	MESH:D019856	MESH:D007249
28292183	Negative_Correlation	MESH:D004298	MESH:D008070
28292183	Negative_Correlation	MESH:C520236	19225
28292183	Negative_Correlation	MESH:C520236	20296
28292183	Negative_Correlation	MESH:D004281	MESH:D019636
28292183	Negative_Correlation	MESH:C520236	20297
28292183	Comparison	MESH:C474941	MESH:C520236
28292183	Association	MESH:D004281	MESH:D019856
28292183	Comparison	MESH:C520236	MESH:D004281
28292183	Comparison	MESH:C520236	MESH:D004298
28292183	Association	MESH:D000588	MESH:D005227
28292183	Negative_Correlation	MESH:C520236	16193
28292183	Negative_Correlation	MESH:D004281	MESH:D007249
28292183	Negative_Correlation	MESH:D012701	MESH:D007249
28292183	Negative_Correlation	MESH:C520236	MESH:D007249
28292183	Negative_Correlation	MESH:D004281	MESH:D010300
28292183	Negative_Correlation	MESH:D008070	MESH:D063388

